News Focus
News Focus
icon url

DewDiligence

10/05/12 11:58 AM

#150107 RE: jbog #150088

B-I’s Rituxan-FoB trial was announced a few weeks ago (#msg-79555847). The ability to run a single trial for both the EU and US markets is a consequence of the EMA policy change posted in #msg-80049942.